Built Environment
Evaluating the safety, effectiveness, and deployment considerations of far-UVC for indoor pathogen mitigation.
Far-UVC light has emerged as a continuous disinfection approach in occupied indoor spaces. The organization strengthens the evidence base, evaluates safety thresholds, examines regulatory considerations, and assesses practical factors relevant to responsible use.
Directed in Far-UVC Research
Research Initiatives Funded
U.S. States with Active Research Projects
Active Research Projects Outside the U.S.
Blueprint Biosecurity supports research advancing the evidence base and informing policy and safety considerations for the deployment of far-UVC.
While far-UVC shows promise, ongoing research continues to examine safety, real-world effectiveness, and regulatory considerations that shape responsible deployment.
Continuing evaluation of long-term eye exposure considerations and secondary effects, including ozone generation, within established safety thresholds.
Expanding real-world evidence on effectiveness across varied indoor conditions, including performance against human-generated aerosols.
Clarifying regulatory alignment and identifying considerations relevant to broader deployment under existing exposure guidelines.
Below is a non-comprehensive list of how far-UVC is being piloted.
Installed as part of layered infection control strategies in clinical settings to support protection for patients and staff.
Deployed in high-occupancy environments, including locker rooms and training facilities, with the goal of reducing transmission risk in shared indoor spaces.
Installed in offices, manufacturing facilities, and other indoor workplaces to support safer shared environments and operational continuity.
Used in educational settings as part of layered strategies to help reduce transmission risk and support continuity of in-person instruction during periods of elevated respiratory illness.
Applied in some agricultural environments to reduce pathogen spread in enclosed spaces and support biosecurity and food system resilience, though deployment in this sector remains in early stages.
Below are projects advancing the evidence base for far-UVC, including safety research, performance evaluation, and regulatory considerations for responsible deployment.
Testing how air cleaning technologies can reduce indoor air pollution created when far-UVC light interacts with common indoor compounds.
Developing an open-source mathematical model that simulates how far-UVC light installations in buildings could reduce the spread of infectious diseases through populations.
Testing human eye tolerance to far-UVC light exposure and establishing safe irradiation limits for practical applications.
Developing a modeling system that shows how far-UVC light disinfects air and affects indoor air chemistry in spaces where people are present.
Developing a modeling system that evaluates how far-UVC light can safely inactivate airborne viruses like influenza in indoor environments.
Researching the short-term eye effects of far-UVC light exposure through quantitative pain assessment and advanced imaging of corneal structures in human volunteers.
Replicating and validating research on the efficacy of far-UVC technology for airborne pathogen inactivation.
Performing field research on secondary chemical reactions produced by far-UVC technology in real-world indoor environments.
Explore recent publications, analysis, and updates related to far-UVC research and indoor pathogen mitigation.